News Autoimmunity
Werfen Annual Report 2018 released
April 29, 2019
Discover more about our financial performance for the year, along with updates on our corporate governance, citizenship, and talent related activities by clicking here.
Share:
NEWS
Latest News
Autoimmunity
September 23, 2026
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
...
Corporate
August 31, 2026 - Bedford, Massachusetts
WERFEN RECEIVES 2026 IMV ServiceTrak™ AWARDS FOR BEST CUSTOMER SATISFACTION, SYSTEM PERFORMANCE AND SERVICE IN COAGULATION
...
Acute Care
May 5, 2026 - Bedford, MA
The risks of in vitro hemolysis and the importance of early detection in critical care medicine — an ICU clinician’s perspective
...
Acute Care
December 11, 2025 - Bedford, MA
WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS
...
